OPKO Health to Participate in the Jefferies Biotech on the Beach Summit MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 2026, at 1 Hotel South Beach in Miami. Management will be holding one-on-one meetings with investors registered for the event on Wednesday, March 11th. Investors interested in scheduling a meeting with OPKO management should contact their Jefferies representative. About OPKO Health OPKO is a multinational biopharmaceutic...
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces financial guidance for the first quarter and full year 2026. Highlights from the fourth quarter of 2025 and recent weeks include the following: Entered into a research collaboration with Regeneron Pharmaceuticals to develop multispecific antibodies. This n...
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference PHILADELPHIA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that the Company will participate in a fireside chat at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at 11:10 a.m. ET in Boston, MA. A live webcast of the presentation will be available on the News an...
A director at AZZ Inc sold 2,923 shares at 136.000USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on Thursday, February 26, 2026. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-r...
Southside Bancshares, Inc. Declares Cash Dividend TYLER, Texas, Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Southside Bancshares, Inc., (NYSE:SBSI), parent company of Southside Bank declared a regular quarterly cash dividend of $0.36 per common share. The cash dividend of $0.36 is scheduled for payment on March 5, 2026, to common stock shareholders of record on February 19, 2026. About Southside Bancshares, Inc. Southside Bancshares, Inc. is a bank holding company headquartered in Tyler, Texas, with approximately $8.51 billion in assets as of December 31, 2025, that whol...
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 PHILADELPHIA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that the Company will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Thursday, February 12, 2026, at 9:30 a.m. ET in New York, NY. A live webcast of the presentation will be availabl...
Bassett Reports Fiscal Fourth Quarter Results BASSETT, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Bassett Furniture Industries, Inc. (Nasdaq: BSET) reported today its results of operations for its fourth quarter ended November 29, 2025. Q4 Consolidated Business Highlights: [FY 25 vs. FY 24, unless otherwise specified] Revenues increased 5.1% from the prior year quarter. Excluding sales from Noa Home Inc., which closed in late 2024, consolidated revenues increased 6.4%.Operating income was $2.3 million or 2.6% of sales as compared to operating income of $0.9 million or 1.1% of sales for the ...
OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism This is the third program that successfully combines Entera’s oral peptide N-Tab® platform with OPKO’s advanced protein chemistry capabilities The companies have accelerated this program and aim to file an investigational new drug (IND) application in late 2026 Injectable and oral oxyntomodulin (dual GLP-1/glucagon analog) for metabolic and fibrotic disorders advancing with initial Phase 1 data from injectable oxyntomodulin (OXM) expected in late 2026; o...
Southside Bancshares, Inc. Announces Financial Results for the Fourth Quarter and Year Ended December 31, 2025 Fourth quarter net income of $21.0 million;Fourth quarter earnings per diluted common share of $0.70;Tax-equivalent net interest margin(1) linked quarter increased four basis points to 2.98%;Annualized return on fourth quarter average assets of 0.99%;Annualized return on fourth quarter average tangible common equity of 13.03(1); andNonperforming assets remain low at 0.45% of total assets. TYLER, Texas, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Southside Bancshares, Inc. (“Southside” or ...
Bassett Announces Fourth Quarter Conference Call BASSETT, Va., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Bassett Furniture Industries, Inc. (Nasdaq: BSET) today announced it will host a conference call with management on Thursday, February 5, 2026, at 9:00 a.m. ET to discuss its fourth quarter 2025 financial results. The Company plans to issue its earnings release after the market closes on Wednesday, February 4, 2026. Rob Spilman, Chairman and CEO will host the call, along with Mike Daniel, Senior Vice President and CFO. The public is invited to listen to the conference call by webcast, accessi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.